Less explored, protein kinase C (PKC) proteins have emerged as possible targets due to their hyperactivity or overexpression, concomitant with the decrease of cell proliferation and invasion verified in preclinical glioma models [6,7,8,9]. This evidence concerns the gene PRRT2 and central nervous system cancer.